[Federal Register Volume 86, Number 137 (Wednesday, July 21, 2021)]
[Notices]
[Page 38492]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15507]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Twelfth Meeting of the National Clinical Care Commission

AGENCY: Office on Women's Health, Office of the Assistant Secretary for 
Health, Office of the Secretary, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) will 
conduct its twelfth and final meeting virtually on September 8, 2021. 
The Commission is charged to evaluate and make recommendations to the 
U.S. Department of Health and Human Services (HHS) Secretary and 
Congress regarding improvements to the coordination and leveraging of 
federal programs related to diabetes and its complications.

DATES: The final meeting will take place September 8, 2021 from 1 p.m. 
to approximately 6 p.m. Eastern Time (ET).

ADDRESSES: The meeting will be held online via webinar. To register to 
attend the meeting, please visit the registration website at https://kauffmaninc.adobeconnect.com/nccc12_2021/event/event_info.html.

FOR FURTHER INFORMATION CONTACT: Kara Elam, Ph.D., MPH, MS, Designated 
Federal Officer, National Clinical Care Commission, U.S. Department of 
Health and Human Services, Office on Women's Health, 200 Independence 
Ave. SW, 7th floor, Washington DC, 20201, Phone: (240) 435-9438, Email: 
[email protected].

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals who represent 
diverse disciplines and views. The Commission will evaluate and make 
recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to diabetes and its complications.
    During the meeting, the Commission will vote to approve the final 
report to be submitted to Congress. The final meeting agenda will be 
available prior to the meeting at https://health.gov/our-work/health-care-quality/national-clinical-care-commission/meetings.
    Public Participation at Meeting: The Commission invites public 
comment on issues related to the Commission's charge. There will be an 
opportunity for limited oral comments (each no more than 3 minutes in 
length) at this virtual meeting. Virtual attendees who plan to provide 
oral comments at the Commission meeting during a designated time must 
register prior to the meeting at https://kauffmaninc.adobeconnect.com/nccc12_2021/event/event_info.html.
    Written comments are welcome throughout the entire development 
process of the Commission's work and may be emailed to [email protected]. 
Written comments should not exceed three pages in length.
    Individuals who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate the 
special accommodation when registering online or by notifying Jennifer 
Gillissen at [email protected] by August 30, 2021.
    Authority: The National Clinical Care Commission is required under 
the National Clinical Care Commission Act (Pub. L. 115-80). The 
Commission is governed by provisions of the Federal Advisory Committee 
Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets 
forth standards for the formation and use of federal advisory 
committees.

    Dated: July 14, 2021.
Dorothy A. Fink,
Deputy Assistant Secretary for Women's Health.
[FR Doc. 2021-15507 Filed 7-20-21; 8:45 am]
BILLING CODE 4150-32-P